CN107021960B - 一种治疗恶性肿瘤的药物 - Google Patents
一种治疗恶性肿瘤的药物 Download PDFInfo
- Publication number
- CN107021960B CN107021960B CN201710434901.5A CN201710434901A CN107021960B CN 107021960 B CN107021960 B CN 107021960B CN 201710434901 A CN201710434901 A CN 201710434901A CN 107021960 B CN107021960 B CN 107021960B
- Authority
- CN
- China
- Prior art keywords
- formula
- drug
- malignant tumour
- fluoro
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710434901.5A CN107021960B (zh) | 2017-06-10 | 2017-06-10 | 一种治疗恶性肿瘤的药物 |
CN201810313204.9A CN108558854A (zh) | 2017-06-10 | 2017-06-10 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710434901.5A CN107021960B (zh) | 2017-06-10 | 2017-06-10 | 一种治疗恶性肿瘤的药物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810313204.9A Division CN108558854A (zh) | 2017-06-10 | 2017-06-10 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107021960A CN107021960A (zh) | 2017-08-08 |
CN107021960B true CN107021960B (zh) | 2018-07-31 |
Family
ID=59531797
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810313204.9A Pending CN108558854A (zh) | 2017-06-10 | 2017-06-10 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
CN201710434901.5A Active CN107021960B (zh) | 2017-06-10 | 2017-06-10 | 一种治疗恶性肿瘤的药物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810313204.9A Pending CN108558854A (zh) | 2017-06-10 | 2017-06-10 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN108558854A (zh) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60037020T2 (de) * | 1999-07-09 | 2008-08-21 | Glaxo Group Ltd., Greenford | Anilinochinazoline als protein-tyrosin-kinasehemmer |
WO2005014585A1 (en) * | 2003-08-08 | 2005-02-17 | Ulysses Pharmaceutical Products Inc. | Halogenated quinazolinyl nitrofurans as antibacterial agents |
JP2007505878A (ja) * | 2003-09-19 | 2007-03-15 | アストラゼネカ アクチボラグ | キナゾリン誘導体 |
CN102250075B (zh) * | 2010-05-21 | 2016-09-21 | 中国医学科学院药物研究所 | 2,4-二取代喹唑啉类化合物、及其制法和药物组合物与用途 |
CN103788085B (zh) * | 2012-10-31 | 2016-09-07 | 复旦大学 | 2-(喹唑啉-4-氨基)-5-噻唑甲酰胺类衍生物及其生物药物用途 |
US9682961B2 (en) * | 2013-12-06 | 2017-06-20 | Carna Biosciences, Inc. | Quinazoline derivative |
RS58597B1 (sr) * | 2014-04-04 | 2019-05-31 | Pfizer | Biciklično-spojena heteroaril ili aril jedinjenja i njihova upotreba kao irak4 inhibitora |
WO2015164374A1 (en) * | 2014-04-22 | 2015-10-29 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
WO2016053769A1 (en) * | 2014-09-30 | 2016-04-07 | Merck Sharp & Dohme Corp. | Inhibitors of irak4 activity |
-
2017
- 2017-06-10 CN CN201810313204.9A patent/CN108558854A/zh active Pending
- 2017-06-10 CN CN201710434901.5A patent/CN107021960B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107021960A (zh) | 2017-08-08 |
CN108558854A (zh) | 2018-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102844023B (zh) | Cdc7激酶抑制剂以及其用途 | |
CN108358973A (zh) | 萘酰亚胺四价铂类化合物、制备方法及其在制备抗肿瘤药物中的应用 | |
CN104211708B (zh) | 苯并噁嗪酮衍生物及其作为抗菌剂的应用 | |
CN105461720B (zh) | 吗啉类酪氨酸激酶抑制剂 | |
WO2014165676A1 (en) | Amphotericin b derivative with reduced toxicity | |
CN105026388B (zh) | 可用作c-fms激酶抑制剂的取代的吡啶衍生物 | |
CN107021960B (zh) | 一种治疗恶性肿瘤的药物 | |
CN107033138B (zh) | 一种治疗恶性肿瘤的药物 | |
CN105012307B (zh) | Imb5046化合物在制备抗肿瘤药物中的用途 | |
WO2017107993A1 (zh) | 聚醚类化合物用途 | |
CN101402667A (zh) | 糖基化修饰的一氧化氮供体型齐墩果酸类化合物、其制备方法及用途 | |
CN110857295A (zh) | 具有选择性抗肝癌作用的黄酮-川芎嗪类化合物ch-x及其制备方法和应用 | |
CN111393368B (zh) | 一种茚并吡唑盐酸盐类衍生物及其制备方法与应用 | |
CN107226815B (zh) | 喹唑啉类化合物及其在抗肿瘤药物中的应用 | |
CN102786458B (zh) | 吡咯甲酰胺衍生物、其制备方法和用途 | |
CN103833693B (zh) | 一种紫杉醇化合物及含该紫杉醇化合物的药物组合物 | |
CN106496542A (zh) | 谷胱甘肽敏感的两亲性聚乙二醇‑羟基喜树碱偶联物 | |
CN110078770A (zh) | 一种具有喹啉酮四价铂结构的化合物、制备方法及其在制备抗肿瘤药物中的应用 | |
CN104292242A (zh) | 噻吩嘧啶类化合物和制剂及其制备方法和应用 | |
CN113072503B (zh) | 亚麻酸-甲硝唑化合物及其制备方法和应用 | |
CN110698457B (zh) | 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-叔丁酯及其用途 | |
CN110845473B (zh) | 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-乙酸乙酯及其用途 | |
CN102276626B (zh) | 含有异恶唑的化合物 | |
CN111995629B (zh) | 大根香叶衍生物及其药物组合物和其在医药中的用途 | |
CN102038676B (zh) | 治疗耐药菌感染的药物及其活性成分在制药中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180619 Address after: No. 200, companion Kun Road, Minhang District, Shanghai Applicant after: Shanghai Pukang Pharmaceutical Co.,Ltd. Address before: 261053 northward 160 meters Road East of Xuanwu Street and Yuhe Road intersection in Kuiwei District, Weifang, Shandong Applicant before: Cao Yan |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A drug for treating malignant tumors Effective date of registration: 20230627 Granted publication date: 20180731 Pledgee: Bank of Hangzhou Limited by Share Ltd. Shanghai branch Pledgor: Shanghai Pukang Pharmaceutical Co.,Ltd. Registration number: Y2023310000315 |